Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy

Molecular & Cellular Proteomics(2020)10.1074/mcp.ra120.002049Source: DataRank Database

High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy is a research paper published in Molecular & Cellular Proteomics (2020). On theSindex it has a DataRank of 0.242. It has been cited 3 times, with 2 citing works in its 1-hop citation network.

N/A

0.242DataRank · unranked

Scored on demand from live citation data

Open Access3 citations · 2 citing works in its network

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 0.11)OA: hybridTopics (72)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 86%Citation Network 14%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

0.0342

From 1 citing papers with measurable signal

Learn more about DataRank methodology →

Top 2 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 2 citers.

c-Met and EPHA7 Receptor Tyrosine Kinases Are Related to Prognosis in Clear Cell Renal Cell Carcinoma: Focusing on the Association with Myoferlin Expression
Cancers20224 citations40 referencesContributes 0.040
Trajectory mapping of renal clear cell carcinoma transcriptomes identifies stage-independent predictors of favorable prognosis
ONCOLOGIE20240 citations36 referencesContributes 0.000

Authors (15)

Benjamin Murter ORCID,John-William Sidhom ORCID,Thomas R. Nirschl ORCID,David Clark ORCID,Li‐Jun Chen ORCID

Live enrichment

PubMed:32737216 OpenAlex:https://openalex.org/W3046759619

HHS | National Institutes of Health

Grant: P30 CA006973

Prostate Cancer Foundation

Grant: YOUNG INVESTIGATOR AWARD

JHU | Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University | Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University

Grant: Start up funds

HHS | NIH | National Cancer Institute

Grant: U01CAI52813

HHS | NIH | National Cancer Institute

Grant: U24CA210985

Maryland Cigarette Restitution Fund

Grant: FHB33CRF

National Institutes of Health

Grant: 5U01CA152813-05

Glycoprotein biomarkers for the early detection of aggressive prostate cancer

National Institutes of Health

Grant: 5R01AI052813-03

MECHANISMS OF BARTONELLA VIRULENCE IN AIDS PATIENTS

National Institutes of Health

Grant: 3P30CA006973-53S2

Regional Oncology Research Center

National Institutes of Health

Grant: 5U24CA210985-03

The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets

NCI NIH HHS

Grant: K22 CA237623

NIGMS NIH HHS

Grant: T32 GM136577

NCI NIH HHS

Grant: U01 CA152813

FWCI

0.11

Citation Percentile

0.5%

Citation Trend

2022

2024

hybridLicense: cc-by

journalhttps://doi.org/10.1074/mcp.ra120.002049

publisherhttps://doi.org/10.1074/mcp.ra120.002049

publisherhttps://api.elsevier.com/content/article/PII:S1535947620351616?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535947620351616?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1074/mcp.RA120.002049

Fields of Study

Ferroptosis and cancer prognosisRenal cell carcinoma treatmentBladder and Urothelial Cancer Treatments0301 basic medicine03 medical and health sciencesBiomarkers, TumorCarcinoma, Renal CellFlow CytometryGene Expression Regulation, NeoplasticGenomicsHumansImmunotherapyKidney NeoplasmsLeukocyte Common AntigensLeukocytes, MononuclearMass SpectrometryPrognosisSignal TransductionTandem Mass SpectrometryTumor Microenvironment

MeSH Terms

Carcinoma, Renal CellFlow CytometryHumansImmunotherapyKidney NeoplasmsLeukocytes, MononuclearPrognosisMass SpectrometryBiomarkers, TumorSignal TransductionGene Expression Regulation, NeoplasticLeukocyte Common AntigensGenomicsTandem Mass SpectrometryTumor Microenvironment

Keywords

MyeloidClear cell renal cell carcinomaImmunotherapyImmune systemRenal cell carcinomaPeripheral blood mononuclear cellCancer researchFlow cytometryBiologyMass cytometryT cellCellImmunologyPathologyMedicineGenePhenotypeResearchGenomicsPrognosisKidney NeoplasmsMass SpectrometryGene Expression Regulation, NeoplasticTandem Mass SpectrometryBiomarkers, TumorLeukocytes, MononuclearTumor MicroenvironmentHumansLeukocyte Common AntigensCarcinoma, Renal CellSignal TransductionExCYTclinical proteomicskidney cancermacrophagesmonocytesperipheral blood mononuclear cells

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being